Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
MENLO PARK, CA--(Marketwired - May 22, 2014) - AntriaBio, Inc. (OTCQB: ANTB) a biopharmaceutical corporation focused on developing novel therapeutics to treat patients with diabetes and metabolic...
-
MENLO PARK, CA--(Marketwired - May 12, 2014) - AntriaBio, Inc. (OTCQB: ANTB) (OTCQB: ANTBD) (ticker will revert back to ANTB on May 21, 2014), a biopharmaceutical corporation focused on developing...
-
MENLO PARK, CA--(Marketwired - May 1, 2014) - AntriaBio, Inc. (OTCQB: ANTB), a biopharmaceutical company focused on developing novel therapeutics to treat patients with diabetes and metabolic...
-
MENLO PARK, CA--(Marketwired - Apr 30, 2014) - AntriaBio, Inc. (OTCQB: ANTB), a biopharmaceutical company focused on developing novel therapeutics to treat patients with diabetes and metabolic...
-
MENLO PARK, CA--(Marketwired - Apr 23, 2014) - AntriaBio, Inc. (OTCQB: ANTB), a biopharmaceutical company focused on developing novel therapeutics to treat patients with diabetes and metabolic...
-
MENLO PARK, CA--(Marketwired - Apr 2, 2014) - AntriaBio, Inc. (OTCQB: ANTB), a biopharmaceutical company focused on developing novel therapeutics for the diabetes market, announced today that in the...
-
MENLO PARK, CA--(Marketwired - Mar 6, 2014) - AntriaBio, Inc. (OTCQB: ANTB), a biopharmaceutical company focused on developing novel therapeutics for the diabetes market, announced today that Nevan...
-
MENLO PARK, CA--(Marketwired - Feb 5, 2014) - AntriaBio, Inc. (OTCQB: ANTB), a biopharmaceutical company focused on developing novel therapeutics for the diabetes market, announced today that the...
-
MENLO PARK, CA--(Marketwired - Jan 16, 2014) - AntriaBio, Inc. (OTCQB: ANTB), a biopharmaceutical company focused on developing novel therapeutics for the diabetes market, announced today that it...
-
AntriaBio Granted European Patent Allowance for Method of Preparing Site-Specific Protein Conjugates
MENLO PARK, CA--(Marketwired - Jul 24, 2013) - AntriaBio, Inc. (OTCQB: ANTB) announced today that it has received an allowance from the European Patent Office for Patent Application No. 04759347.0...